People with MS who also have heart-related conditions (like high blood pressure, diabetes, or high cholesterol) tend to feel more tired, and more conditions mean more fatigue over time.
Researchers looked at over 5,500 people with MS and measured fatigue using a patient questionnaire. They counted whether each person had none, one, two, or three cardiovascular conditions: high blood pressure, diabetes, or high cholesterol. At one point in time, having any of these conditions was linked to feeling more tired, and having more conditions was linked to even more fatigue. When the researchers also considered depression, anxiety, and sleep problems, the link became smaller but still followed the same pattern. Over months or years, the link stayed and even grew stronger, meaning people with more heart-related conditions tended to get or stay more fatigued over time.
People with MS and their caregivers should care because managing heart-related health may help reduce how tired someone feels—think of it like fixing leaks to keep a house dryer: each leak (condition) makes the house worse off. Doctors and MS care teams should pay attention to blood pressure, blood sugar, and cholesterol because treating these could be another way to help with fatigue. Caregivers can support tasks like medication reminders, healthy meals, and gentle activity, which help both heart health and energy. People with MS who already have one or more of these conditions should watch their fatigue more closely, since the study shows fatigue is likely to be higher and may persist. Even if you don’t have these conditions now, healthy habits that protect the heart (like balanced eating, safe exercise, and regular check-ups) could help keep fatigue lower.
This study shows a link but does not prove that heart conditions cause the extra fatigue—other things could play a role. The link became smaller after accounting for depression, anxiety, and sleep problems, so those issues also matter and can affect how tired someone feels. The results come from clinic data and questionnaires, so individual experiences may vary and a doctor should help decide what steps are best for each person.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.